Announcement
20 May 2020
In May 2020, the Norwegian authorities introduced an export ban on formoterol, glycopyrronium bromide and beclomethasone due to concerns of domestic shortages following the COVID-19 pandemic. In June 2020, the export ban was terminated.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
20 May 2020
Revocation date:
14 Jun 2020
Updated: 20 May 2020
Export ban
On 20 May 2020, the Norwegian Medicines Agency introduced an export ban on formoterol, glycopyrronium bromide and beclomethasone. The export ban was introduced due to concerns of domestic shortages...
Sign in to see more
Related State Acts
03 Jul 2020
Norway: Introduction and subsequent termination of export ban on formoterol and budesonide (COVID-19)
15 Jun 2020
Norway: Introduction of export notification requirement on several pharmaceutical goods (COVID-19)
21 Apr 2020
Norway: Introduction of export notification requirement on medications for treating obstructive pulmonary diseases following the COVID-19 outbreak
Threads
See all
This state act is not part of any Thread yet.